JUVE Patent

Nicola Dagg is a partner in the IP litigation team in the London office of Kirkland & Ellis International LLP. Nicola’s practice spans four areas:

►(1) strategic life sciences patent and product lifecycle advice;

►(2) patent litigation;

►(3) coordinating global IP enforcement/defence cases; and

►(4) standard essential patent (SEP) and FRAND disputes.

Nicola has extensive experience on all aspects of intellectual property advisory and litigation work, including blockbuster small molecule litigation against generic companies, biologics and biosimilar litigation, antibodies, immunotherapies, genetics, vaccines, diagnostics and gene therapies. Nicola also acts in market leading SEP essentiality, validity and global FRAND adjudication litigation in the tech sector. Having served as UK and European/global co-ordinating counsel for numerous strategic IP projects litigation cases and drawing on almost 30 years of legal, IP, life sciences and tech experience she helps clients solve their most pressing global IP challenges.

Nicola writes and speaks extensively on intellectual property litigation. She is ranked as a leading Tier 1 IP partner in Chambers Global, Chambers UK, JUVE Patent and The Legal 500. Chambers UK 2025 recognises Nicola as a “force of nature” who is “tremendous strategist and creative thinker who never loses sight of the commercial goal.” The Legal 500 UK named Nicola a “Hall of Fame” attorney in the Intellectual Property Patents category, as well as a leading individual in Life Sciences and Healthcare. The 2025 edition refers to Nicola as “able to utilise her legal talent to obtain fantastic results.”

Nicola has consistently been recognised as a gold-ranked patent litigator by IAM Patent 1000 and in their 2023 directory they describe her as “a fearsome practitioner respected by all in the market… she delivers top quality strategic advice.”